1349036-99-2

Basic information

• Product Name: (1R)-1-(3-bromophenyl)-1-(2-(difluoromethyl)pyridin-4-yl)-4-fluoro-1H-isoindol-3-amine
• Synonyms: (1R)-1-(3-bromophenyl)-1-(2-(difluoromethyl)pyridin-4-yl)-4-fluoro-1H-isoindol-3-amine
• CAS NO: 1349036-99-2
• Molecular Weight: 432.243
• Mol File: 1349036-99-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (1R)-1-(3-bromophenyl)-1-(2-(difluoromethyl)pyridin-4-yl)-4-fluoro-1H-isoindol-3-amine(CAS DataBase Reference)
• NIST Chemistry Reference: (1R)-1-(3-bromophenyl)-1-(2-(difluoromethyl)pyridin-4-yl)-4-fluoro-1H-isoindol-3-amine(1349036-99-2)
• EPA Substance Registry System: (1R)-1-(3-bromophenyl)-1-(2-(difluoromethyl)pyridin-4-yl)-4-fluoro-1H-isoindol-3-amine(1349036-99-2)

Safety Data

• Hazardous Substances Data: 1349036-99-2(Hazardous Substances Data)

Upstream product

• 1225047-28-8 2-(difluoromethyl)isonicotinoyl chloride 
• 1256818-14-0 2-(difluoromethyl)isonicotinic acid 
• 1349036-90-3 3-fluoro-2-cyanophenyl (2-(difluoromethyl)pyridin-4-yl) ketone 
• 108-36-1 1,3-dibromobenzene 
• 1349036-94-7 (R)-3-fluoro-2-cyanophenyl (2-(difluoromethyl)pyridin-4-yl) N-tert-butylsulfinyl imine 

Relevant articles and documents

HEMIFUMARATE SALT

The present invention relates to a hemifumarate salt of the compound (1S)-1-(2-(difluoromethyl)pyridin-4-yl)-4-fluoro-1-(3-(pyrimidin-5-yl)phenyl)-1H-isoindol-3-amine, Form A thereof and its pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of Aβ-related pathologies such as Downs syndrome, β-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer Disease, memory loss, attention deficit symptoms associated with Alzheimer disease, neurodegeneration associated with diseases such as Alzheimer disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.